February 8, 2021
LONGMONT, Colo. -- ANDE Corporation, the global leader in Rapid DNA, today announced the availability of its Rapid DNA Booking Management product suite, which is available for immediate delivery. Effective February 1, 2021, ANDE received approval from the FBI for its technology to be deployed in booking stations to support processing of DNA samples from [...]
February 8, 2021
CELLINK AB and seqWell, Inc. have entered into an agreement in which CELLINK will commercialize seqWell's products, including the upcoming plexWell Single-cell Rapid Kit for plate-based single-cell RNA sequencing, to a wider audience outside the United States. The agreement encompasses seqWell's full line of plexWell library preparation kits for a wide range of multiplexed NGS [...]
Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
February 8, 2021
Commitment from Cornerstone Investor LifeArc to Advance Genomics Startups in the UK SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, [...]
February 8, 2021
Lausanne, Switzerland and Boston, MA, USA – February 8, 2021: SOPHiA GENETICS, a global leader in Data-Driven Medicine, announced today a clinical research partnership initiative with the Spanish Lung Cancer Group to apply its radiomics and multimodal analysis capabilities to predict response to neoadjuvant chemoimmunotherapy in resectable stage IIIA non-small cell lung cancer (NSCLC). The collaboration [...]
February 8, 2021
RENO, Nev.-- Bioelectronica Corporation ("Bioelectronica") today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The Series A investment was led by Proxima Ventures with follow-on investment by Co-win Ventures. The team at Proxima, experienced investors in [...]
seqWell launches plexWell™ Single-cell Rapid Kit for streamlined scRNA Sequencing
February 5, 2021
BEVERLY, Mass. -- SeqWell, a leader in genomic technologies, announced the release of its plexWell Single Cell Rapid Kit, simplifying and accelerating the preparation of NGS libraries for single-cell RNA sequencing. plexWell Single Cell Rapid is the first in a series of products in the single-cell analysis area and offers a comprehensive library prep solution employing [...]
February 5, 2021
CANNON CAV® 4.1: Single Bath Kinematic Viscometer for ASTM D445/446 Testing of Transparent and Opaque Liquids The CANNON CAV 4.1 is a fully-automated, single bath, benchtop kinematic viscometer with two 14-position sample handlers for unattended ASTM D445/446 testing. Each of the two Ubbelohde-style tubes covers a 100-fold viscosity range at values between 0.5 mm2/s (cSt) and [...]
February 4, 2021
EASTON, Pa.-- Follett Products, LLC (Follett), a division of The Middleby Corporation, and PHC Corporation of North America (PHCNA) announced a partnership to market and sell the PHCbi line of ultra-low temperature (ULT) freezers, pharmaceutical grade refrigerators, and biomedical freezers to Follett’s healthcare customers. These products will be offered alongside Follett’s existing portfolio of high-performance [...]
Berkeley Lights Announces CFO Transition and C-Level Additions
February 4, 2021
Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights Company to Report Fourth Quarter and Year-End 2020 Financial Results on February 25, 2021 EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, announced today the following organizational updates: Kurt Wood, currently [...]
February 4, 2021
LEBANON, N.H., -- Avitide, Inc. the industry leader in the discovery and development of affinity purification chromatography resins, announced that it has finalized the development of an affinity bioprocess resin for the purification of recombinant COVID-19 vaccines. The AVIPure®-COV2S resin delivers outstanding performance as a capture resin for the majority of recombinant COVID-19 vaccines. The [...]
